Federal Circuit affirms validity of Pressure Products’ patent infringement case against Greatbatch Medical

In the most recent development concerning Pressure Products’ patent infringement case against Greatbatch Medical’s valved, peelable introducer product line, The United States Court of Appeals for the Federal Circuit has affirmed the rulings of United States District Court for the Eastern District of Texas that Pressure Products’ patents are valid and enforceable. In a split decision, the Federal Circuit remanded the case to the District Court for further proceedings concerning Greatbatch’s infringement of Pressure Products’ patents.

“Moreover, despite the majority opinion in the split decision, we are pleased that Judge Newman agreed with our position. Therefore, we will be proceeding according to the Federal Circuit’s Order to enforce our patents against Greatbatch in the District Court.”

“We are pleased that the Federal Circuit has affirmed the validity of Pressure Products’ patents,” said Dr. Paul Kurth, President of Pressure Products. “Moreover, despite the majority opinion in the split decision, we are pleased that Judge Newman agreed with our position. Therefore, we will be proceeding according to the Federal Circuit’s Order to enforce our patents against Greatbatch in the District Court.”

Source:

Pressure Products

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.